Review
. 2020 Jun; 9(6):.
doi: 10.3390/cells9061376.

PD-1: Its Discovery, Involvement in Cancer Immunotherapy, and Beyond

Yasumasa Ishida 1 
Affiliations
  • PMID: 32492969
  •     37 References
  •     7 citations

Abstract

On December 10, 2018, I was sitting among the big crowd of audience, as one of the invited guests to the ceremony, in the Stockholm Concert Hall. When King of Sweden Carl XVI Gustaf bestowed the diploma and medal of Nobel Prize of Physiology or Medicine 2018 on Dr. Tasuku Honjo and shook his hand for a while, surrounded by the thunderous applause and energetically blessing orchestral music, I thought that it had been a long journey for the molecule that we had first isolated in the early 1990s. Although it was truly a commemorable moment in the history of the programmed death-1 (PD-1) research, I believe we still have a long way to go. In this review article, I will explain why I think so, particularly by focusing on the potential role(s) that PD-1 appears to play in self-nonself discrimination by the immune system.

Keywords: PD-1; T cell; cancer; immunotherapy; self-nonself discrimination; subtractive hybridization.

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.
H Nishimura, T Okazaki, +8 authors, T Honjo.
Science, 2001 Feb 24; 291(5502). PMID: 11209085
Highly Cited.
The mouse T cell receptor: comparison of MHC-restricted receptors on two T cell hybridomas.
J Kappler, R Kubo, +2 authors, P Marrack.
Cell, 1983 Oct 01; 34(3). PMID: 6605198
Highly Cited.
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.
J Yuan, S Shaham, +2 authors, H R Horvitz.
Cell, 1993 Nov 19; 75(4). PMID: 8242740
Highly Cited.
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Y Ishida, Y Agata, K Shibahara, T Honjo.
EMBO J, 1992 Nov 01; 11(11). PMID: 1396582    Free PMC article.
Highly Cited.
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
P Waterhouse, J M Penninger, +6 authors, T W Mak.
Science, 1995 Nov 10; 270(5238). PMID: 7481803
Highly Cited.
Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins.
S M Hedrick, E A Nielsen, +2 authors, M M Davis.
Nature, 1984 Mar 08; 308(5955). PMID: 6546606
Highly Cited.
Genetic control of programmed cell death in the nematode C. elegans.
H M Ellis, H R Horvitz.
Cell, 1986 Mar 28; 44(6). PMID: 3955651
Highly Cited.
Enhancement of antitumor immunity by CTLA-4 blockade.
D R Leach, M F Krummel, J P Allison.
Science, 1996 Mar 22; 271(5256). PMID: 8596936
Highly Cited.
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Matthew M Gubin, Xiuli Zhang, +24 authors, Robert D Schreiber.
Nature, 2014 Nov 28; 515(7528). PMID: 25428507    Free PMC article.
Highly Cited.
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.
H Zou, W J Henzel, +2 authors, X Wang.
Cell, 1997 Aug 08; 90(3). PMID: 9267021
Highly Cited.
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
E A Tivol, F Borriello, +3 authors, A H Sharpe.
Immunity, 1995 Nov 01; 3(5). PMID: 7584144
Highly Cited.
Somatic generation of antibody diversity.
S Tonegawa.
Nature, 1983 Apr 14; 302(5909). PMID: 6300689
Highly Cited. Review.
Cell growth cycle block of T cell hybridomas upon activation with antigen.
J D Ashwell, R E Cunningham, P D Noguchi, D Hernandez.
J Exp Med, 1987 Jan 01; 165(1). PMID: 3491868    Free PMC article.
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.
S M Hedrick, D I Cohen, E A Nielsen, M M Davis.
Nature, 1984 Mar 08; 308(5955). PMID: 6199676
Highly Cited.
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.
Mark J Selby, John J Engelhardt, +4 authors, Alan J Korman.
Cancer Immunol Res, 2014 Apr 30; 1(1). PMID: 24777248
Highly Cited.
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.
Y Agata, A Kawasaki, +4 authors, T Honjo.
Int Immunol, 1996 May 01; 8(5). PMID: 8671665
Highly Cited.
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses.
Daisuke Sugiura, Takumi Maruhashi, +4 authors, Taku Okazaki.
Science, 2019 Apr 20; 364(6440). PMID: 31000591
Highly Cited.
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.
Yoshiko Iwai, Masayoshi Ishida, +3 authors, Nagahiro Minato.
Proc Natl Acad Sci U S A, 2002 Sep 10; 99(19). PMID: 12218188    Free PMC article.
Highly Cited.
Caenorhabditis elegans gene ced-9 protects cells from programmed cell death.
M O Hengartner, R E Ellis, H R Horvitz.
Nature, 1992 Apr 09; 356(6369). PMID: 1560823
Highly Cited.
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Frederick Arce Vargas, Andrew J S Furness, +32 authors, Sergio A Quezada.
Cancer Cell, 2018 Mar 27; 33(4). PMID: 29576375    Free PMC article.
Highly Cited.
The mouse T cell receptor: structural heterogeneity of molecules of normal T cells defined by xenoantiserum.
B W McIntyre, J P Allison.
Cell, 1983 Oct 01; 34(3). PMID: 6194888
Highly Cited.
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
D L Vaux, S Cory, J M Adams.
Nature, 1988 Sep 29; 335(6189). PMID: 3262202
Highly Cited.
Current issues and perspectives in PD-1 blockade cancer immunotherapy.
Kenji Chamoto, Ryusuke Hatae, Tasuku Honjo.
Int J Clin Oncol, 2020 Jan 05; 25(5). PMID: 31900651    Free PMC article.
Review.
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures.
C A Smith, G T Williams, +2 authors, J J Owen.
Nature, 1989 Jan 12; 337(6203). PMID: 2521375
Highly Cited.
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.
H Nishimura, M Nose, +2 authors, T Honjo.
Immunity, 1999 Sep 15; 11(2). PMID: 10485649
Highly Cited.
A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.
Y Yanagi, Y Yoshikai, +3 authors, T W Mak.
Nature, 1984 Mar 08; 308(5955). PMID: 6336315
Highly Cited.
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
T Okazaki, A Maeda, +2 authors, T Honjo.
Proc Natl Acad Sci U S A, 2001 Nov 08; 98(24). PMID: 11698646    Free PMC article.
Highly Cited.
The cancer genome.
Michael R Stratton, Peter J Campbell, P Andrew Futreal.
Nature, 2009 Apr 11; 458(7239). PMID: 19360079    Free PMC article.
Highly Cited. Review.
Coinhibitory Pathways in Immunotherapy for Cancer.
Susanne H Baumeister, Gordon J Freeman, Glenn Dranoff, Arlene H Sharpe.
Annu Rev Immunol, 2016 Mar 02; 34. PMID: 26927206
Highly Cited. Review.
Driver and passenger mutations in cancer.
Julia R Pon, Marco A Marra.
Annu Rev Pathol, 2014 Oct 24; 10. PMID: 25340638
Highly Cited. Review.
The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors.
O Acuto, R E Hussey, +4 authors, E L Reinherz.
Cell, 1983 Oct 01; 34(3). PMID: 6605197
Highly Cited.
Immunoglobulin genes.
T Honjo.
Annu Rev Immunol, 1983 Jan 01; 1. PMID: 6443559
Highly Cited. Review.
MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Elise Alspach, Danielle M Lussier, +20 authors, Robert D Schreiber.
Nature, 2019 Oct 28; 574(7780). PMID: 31645760    Free PMC article.
Highly Cited.
Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.
Y Tsujimoto, L R Finger, +2 authors, C M Croce.
Science, 1984 Nov 30; 226(4678). PMID: 6093263
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation.
D S Ucker, J D Ashwell, G Nickas.
J Immunol, 1989 Dec 01; 143(11). PMID: 2479679
Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok.
Science, 2018 Mar 24; 359(6382). PMID: 29567705    Free PMC article.
Highly Cited. Review.
PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis.
Ewelina Grywalska, Iwona Smarz-Widelska, +7 authors, Wojciech Załuska.
Int J Mol Sci, 2020 Oct 31; 21(21). PMID: 33121190    Free PMC article.
Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer.
Gaber Plavc, Tanja Jesenko, Miha Oražem, Primož Strojan.
Cancers (Basel), 2020 Nov 05; 12(11). PMID: 33143094    Free PMC article.
Review.
PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines.
Mohammed Safi, Hyat Ahmed, +6 authors, Jiwei Liu.
J Adv Res, 2021 Apr 13; 29. PMID: 33842004    Free PMC article.
Review.
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.
Shannon M Liudahl, Courtney B Betts, +27 authors, Lisa M Coussens.
Cancer Discov, 2021 Mar 18; 11(8). PMID: 33727309    Free PMC article.
Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions.
Kamil Grubczak, Anna Kretowska-Grunwald, +9 authors, Marcin Moniuszko.
Cells, 2021 Aug 28; 10(8). PMID: 34440813    Free PMC article.
Emerging concepts in PD-1 checkpoint biology.
Kristen E Pauken, James A Torchia, +2 authors, Gordon J Freeman.
Semin Immunol, 2021 May 20; 52. PMID: 34006473    Free PMC article.
Review.
Novel Murine Pancreatic Tumor Model Demonstrates Immunotherapeutic Control of Tumor Progression by a Toxoplasma gondii Protein.
Susan N Payne, Philip B Emmerich, +2 authors, Laura J Knoll.
Infect Immun, 2021 Sep 21; 89(12). PMID: 34543124    Free PMC article.